Compare JNJ & ERC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | JNJ | ERC |
|---|---|---|
| Founded | 1886 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 589.2B | 262.0M |
| IPO Year | 1944 | N/A |
| Metric | JNJ | ERC |
|---|---|---|
| Price | $243.50 | $9.40 |
| Analyst Decision | Buy | |
| Analyst Count | 17 | 0 |
| Target Price | ★ $227.29 | N/A |
| AVG Volume (30 Days) | ★ 9.2M | 64.4K |
| Earning Date | 01-21-2026 | 01-01-0001 |
| Dividend Yield | 2.13% | ★ 8.37% |
| EPS Growth | ★ 71.26 | N/A |
| EPS | ★ 11.03 | 0.72 |
| Revenue | ★ $94,193,000,000.00 | N/A |
| Revenue This Year | $6.63 | N/A |
| Revenue Next Year | $7.21 | N/A |
| P/E Ratio | $22.17 | ★ $12.92 |
| Revenue Growth | ★ 5.08 | N/A |
| 52 Week Low | $141.50 | $8.51 |
| 52 Week High | $246.35 | $9.74 |
| Indicator | JNJ | ERC |
|---|---|---|
| Relative Strength Index (RSI) | 83.07 | 49.52 |
| Support Level | $237.40 | $9.37 |
| Resistance Level | $246.35 | $9.56 |
| Average True Range (ATR) | 3.66 | 0.07 |
| MACD | 0.87 | -0.00 |
| Stochastic Oscillator | 90.12 | 25.00 |
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
Allspring Multi-Sector Income Fund is a closed-end investment management company. The company's core business is to secure a high level of income for its investors consistent with limiting its overall exposure to domestic interest rate risk. It invests in U.S. dollar-denominated below investment-grade bonds, debentures, and other income obligations, including loans and preferred stocks, developed and emerging market debt securities, including obligations of foreign governments or governmental entities, foreign corporations, or supranational agencies denominated in various currencies, asset backed securities and investment grade corporate bonds.